ARCHIVES

SWOG Opens Phase II Trial Of CuraGen’s HDAC Inhibitor For B-Cell Lymphoma

This article is from The Cancer Letter archive.

Vol. 29 No. 9 | September 29, 2006

Download PDF Visit The Full Archive

Related Articles

UNC Lineberger Appoints Two, Zaret Wins Chair At Fox Chase.

February 25, 2000

Centers’ Problems Get Increasing Attention From Staff, Advisors

August 20, 1976

Ohio Center Helps Women Stop Smoking, Reduce Cervical Cancer Risk

October 29, 2004

Pragmatists vs. Purists: Colon Cancer Screening Guideline Triggers Debate.

October 10, 2008

DCT Moves Fast to Take Control Of Cooperative Groups, Get Multimodality Studies Under Way

October 3, 1975

In Brief: Cancer Program Bill Renews Congressional Commitment To Principles, Rep. Carter Says

May 5, 1978